KAT3B/p300 Antibody (RW105) [CoraFluor™ 1]
Novus Biologicals, part of Bio-Techne | Catalog # NB100-616CL1
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human, Mouse, Rat, Mustelid, Primate
Applications
Western Blot, Flow Cytometry, Flow (Intracellular), Immunocytochemistry/ Immunofluorescence, Immunoprecipitation, Chromatin Immunoprecipitation (ChIP), In vitro assay, Knockdown Validated, Electron Microscopy, Serum
Label
CoraFluor 1
Antibody Source
Monoclonal Mouse IgG1 kappa Clone # RW105
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Fusion protein containing residues 1572-2371 of human KAT3B/p300. [UniProt# Q0947]
Specificity
This is specific for p300 protein. This recognizes residues 1921-2023.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1 kappa
Applications for KAT3B/p300 Antibody (RW105) [CoraFluor™ 1]
Application
Recommended Usage
Serum
In-vitro
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein G purified
Formulation
PBS
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark. Do not freeze.
Background: p300
Long Name
E1A-binding Protein p300
Alternate Names
EP300
Gene Symbol
EP300
Additional p300 Products
Product Documents for KAT3B/p300 Antibody (RW105) [CoraFluor™ 1]
Product Specific Notices for KAT3B/p300 Antibody (RW105) [CoraFluor™ 1]
CoraFluor (TM) is a trademark of Bio-Techne Corp. Sold for research purposes only under agreement from Massachusetts General Hospital. US patent 2022/0025254
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...